Viridian Therapeutics Inc (NASDAQ: VRDN) is -38.15% lower on its value in year-to-date trading and has touched a low of $10.93 and a high of $24.18 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The VRDN stock was last observed hovering at around $14.84 in the last trading session, with the day’s loss setting it -1.37%.
Currently trading at $13.47, the stock is -10.69% and -8.08% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.63 million and changing -9.23% at the moment leaves the stock -18.16% off its SMA200. VRDN registered -30.39% loss for a year compared to 6-month loss of -27.46%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -11.15% gain in the last 1 month and extending the period to 3 months gives it a 9.16%, and is -9.48% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.54% over the week and 5.76% over the month.
Viridian Therapeutics Inc (VRDN) has around 96 employees, a market worth around $860.60M and $0.29M in sales. Profit margin for the company is -79185.76%. Distance from 52-week low is 23.30% and -44.29% from its 52-week high. The company has generated returns on investments over the last 12 months (-37.77%).
The EPS is expected to grow by 27.36% this year
205.0 institutions hold shares in Viridian Therapeutics Inc (VRDN), with institutional investors hold 111.07% of the company’s shares. The shares outstanding are 63.89M, and float is at 55.55M with Short Float at 14.40%. Institutions hold 111.06% of the Float.
The top institutional shareholder in the company is FMR LLC with over 9.57 million shares valued at $124.55 million. The investor’s holdings represent 15.6686 of the VRDN Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 4.77 million shares valued at $62.1 million to account for 7.8129 of the shares outstanding. The other top investors are DEEP TRACK CAPITAL, LP which holds 3.92 million shares representing 6.4221 and valued at over $51.05 million, while VR ADVISER, LLC holds 6.3547 of the shares totaling 3.88 million with a market value of $50.51 million.
Viridian Therapeutics Inc (VRDN) Insider Activity
The most recent transaction is an insider purchase by Fairmount Funds Management LLC, the company’s Director. SEC filings show that Fairmount Funds Management LLC bought 476,190 shares of the company’s common stock on Jan 22 ’24 at a price of $21.00 per share for a total of $10.0 million. Following the purchase, the insider now owns 1.84 million shares.
